Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
NCT ID: NCT01011933
Description: None
Frequency Threshold: 5
Time Frame: Adverse Events(AEs) are reported up to 30 days after last treatment. Late AEs can be reported up to 5 years after patient enrollment.
Study: NCT01011933
Study Brief: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Treatment (Selumetinib) Patients receive selumetinib PO twice daily on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Blood and archived tumor tissue samples are collected for biomarker studies. None None 32 50 38 50 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Dysphagia None Gastrointestinal disorders CTCAE (3.0) View
Mucositis (Functional/Sympt) - Oral Cavity None Gastrointestinal disorders CTCAE (3.0) View
Obstruction, Gi - Small Bowel Nos None Gastrointestinal disorders CTCAE (3.0) View
Dehydration None Gastrointestinal disorders CTCAE (3.0) View
Constipation None Gastrointestinal disorders CTCAE (3.0) View
Hemorrhage, Gi - Rectum None Vascular disorders CTCAE (3.0) View
Liver Dysfunction None Hepatobiliary disorders CTCAE (3.0) View
Inf Unknown Anc: Skin (Cellulitis) None Infections and infestations CTCAE (3.0) View
Edema: Limb None Blood and lymphatic system disorders CTCAE (3.0) View
Dizziness None Nervous system disorders CTCAE (3.0) View
Neuropathy-Sensory None Nervous system disorders CTCAE (3.0) View
Ocular/Visual - Other None Eye disorders CTCAE (3.0) View
Pain: Chest /Thorax Nos None General disorders CTCAE (3.0) View
Pain: Abdominal Pain Nos None General disorders CTCAE (3.0) View
Dyspnea None Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Obstruction, Gu - Ureter None Renal and urinary disorders CTCAE (3.0) View
Vaginitis None Reproductive system and breast disorders CTCAE (3.0) View
Thrombosis/Thrombus/Embolism None Vascular disorders CTCAE (3.0) View
Leukocytes None Blood and lymphatic system disorders CTCAE (3.0) View
Hemoglobin None Blood and lymphatic system disorders CTCAE (3.0) View
S/N Arrhythmia: Atrial Fibrillation None Cardiac disorders CTCAE (3.0) View
Hypotension None Cardiac disorders CTCAE (3.0) View
Death No Ctcae Term - Disease Progression Nos None General disorders CTCAE (3.0) View
Death No Ctcae Term - Death Nos None General disorders CTCAE (3.0) View
Rash None Skin and subcutaneous tissue disorders CTCAE (3.0) View
Hyponatremia None Metabolism and nutrition disorders CTCAE (3.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Neutrophils None Blood and lymphatic system disorders CTCAE (3.0) View
Platelets None Blood and lymphatic system disorders CTCAE (3.0) View
Leukocytes None Blood and lymphatic system disorders CTCAE (3.0) View
Hemoglobin None Blood and lymphatic system disorders CTCAE (3.0) View
Hypotension None Cardiac disorders CTCAE (3.0) View
Ptt None Vascular disorders CTCAE (3.0) View
Weight Gain None General disorders CTCAE (3.0) View
Fever None General disorders CTCAE (3.0) View
Rigors/Chills None General disorders CTCAE (3.0) View
Fatigue None General disorders CTCAE (3.0) View
Insomnia None General disorders CTCAE (3.0) View
Acne None Skin and subcutaneous tissue disorders CTCAE (3.0) View
Rash None Skin and subcutaneous tissue disorders CTCAE (3.0) View
Dry Skin None Skin and subcutaneous tissue disorders CTCAE (3.0) View
Pruritus None Skin and subcutaneous tissue disorders CTCAE (3.0) View
Flatulence None Gastrointestinal disorders CTCAE (3.0) View
Heartburn None Gastrointestinal disorders CTCAE (3.0) View
Taste Alteration None Gastrointestinal disorders CTCAE (3.0) View
Dry Mouth None Gastrointestinal disorders CTCAE (3.0) View
Mucositis (Clinical Exam) - Oral Cavity None Gastrointestinal disorders CTCAE (3.0) View
Vomiting None Gastrointestinal disorders CTCAE (3.0) View
Anorexia None Gastrointestinal disorders CTCAE (3.0) View
Constipation None Gastrointestinal disorders CTCAE (3.0) View
Nausea None Gastrointestinal disorders CTCAE (3.0) View
Diarrhea None Gastrointestinal disorders CTCAE (3.0) View
Hemorrhage/Pulmonary - Nose None Vascular disorders CTCAE (3.0) View
Inf W/Nml Or Gr 1 Or 2 Anc: Urinary Tract Nos None Infections and infestations CTCAE (3.0) View
Edema: Trunk/Genital None Blood and lymphatic system disorders CTCAE (3.0) View
Edema: Limb None Blood and lymphatic system disorders CTCAE (3.0) View
Edema: Head And Neck None Blood and lymphatic system disorders CTCAE (3.0) View
Ast None Metabolism and nutrition disorders CTCAE (3.0) View
Creatinine None Metabolism and nutrition disorders CTCAE (3.0) View
Hypoalbuminemia None Metabolism and nutrition disorders CTCAE (3.0) View
Alt None Metabolism and nutrition disorders CTCAE (3.0) View
Alkaline Phosphatase None Metabolism and nutrition disorders CTCAE (3.0) View
Hypophosphatemia None Metabolism and nutrition disorders CTCAE (3.0) View
Hyponatremia None Metabolism and nutrition disorders CTCAE (3.0) View
Hypocalcemia None Metabolism and nutrition disorders CTCAE (3.0) View
Hyperkalemia None Metabolism and nutrition disorders CTCAE (3.0) View
Hyperglycemia None Metabolism and nutrition disorders CTCAE (3.0) View
Hypokalemia None Metabolism and nutrition disorders CTCAE (3.0) View
Hypoglycemia None Metabolism and nutrition disorders CTCAE (3.0) View
Hypomagnesemia None Metabolism and nutrition disorders CTCAE (3.0) View
Mood Alteration - Depression None Nervous system disorders CTCAE (3.0) View
Mood Alteration - Anxiety None Nervous system disorders CTCAE (3.0) View
Dizziness None Nervous system disorders CTCAE (3.0) View
Neuropathy-Sensory None Nervous system disorders CTCAE (3.0) View
Blurred Vision None Eye disorders CTCAE (3.0) View
Pain: Extremity-Limb None General disorders CTCAE (3.0) View
Pain: Back None General disorders CTCAE (3.0) View
Pain: Joint None General disorders CTCAE (3.0) View
Pain: Abdominal Pain Nos None General disorders CTCAE (3.0) View
Cough None Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Dyspnea None Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Thrombosis/Thrombus/Embolism None Vascular disorders CTCAE (3.0) View